Skip to main content
. 2024 Feb 13;39(1):2311157. doi: 10.1080/14756366.2024.2311157

Table 2.

Cytotoxicity of compound 5 and erlotinib over HCT-116, HEPG-2, and HPrEC (IC50, µM).

Compound Cytotoxic activity IC50 (µM)a
HCT-116 HEPG-2 HPrEC
5 19.80 ± 0.55 14.24 ± 1.20 95.54 ± 1.30
Erlotinib 17.81 ± 1.15 22.06 ± 0.46 63.47 ± 5.56
a

IC50 values represent mean ± SD of three experiments.